ANNE MONTE-PARKER: Open Payments
NPI 1518514025 · HICKORY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,078 in 64 payments from 19 companies in 2025. Trend: 2023 $1,048 · 2024 $1,111 · 2025 $1,078
Food & beverage: $1,078
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $393 |
| Madrigal Pharmaceuticals | 4 | $125 |
| Phathom Pharmaceuticals, Inc. | 5 | $67 |
| PFIZER INC. | 3 | $64 |
| Novo Nordisk Inc | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| GlaxoSmithKline, LLC. | 1 | $29 |
Products named: REZDIFFRA, UBRELVY, VRAYLAR, VOQUEZNA, VELSIPITY, CREON, SKYRIZI, ZENPEP.
Industry payments across NC — which companies pay providers there.
